Sort   by:  
 Page size 
UnknownFecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host.
Not available
S-EPMC4863031 | biostudies-literature
UnknownResults of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.
Not available
S-EPMC4298760 | biostudies-literature
UnknownTreatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.
Not available
S-EPMC5508077 | biostudies-literature
UnknownMelphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Not available
S-EPMC5830386 | biostudies-literature
UnknownFrontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.
Not available
S-EPMC4705425 | biostudies-literature
UnknownRac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.
Not available
S-EPMC3359741 | biostudies-literature
UnknownResults from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
Not available
S-EPMC3069671 | biostudies-literature
Sort   by:  
 Page size